Filing Details

Accession Number:
0001144204-16-125866
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-28 21:00:19
Reporting Period:
2016-09-26
Filing Date:
2016-09-28
Accepted Time:
2016-09-28 21:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1270073 Intercept Pharmaceuticals Inc ICPT Pharmaceutical Preparations (2834) 223868459
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559570 David Shapiro C/O Intercept Pharmaceuticals, Inc.
450 W. 15Th Street, Suite 505
New York NY 10011
Cmo And Evp - Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-09-26 2,659 $164.76 45,732 No 4 S Direct
Common Stock Disposition 2016-09-26 886 $166.03 44,846 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person.
  2. This transaction was executed in multiple trades at prices ranging from $164.5201 to $165.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.